Filing Details

Accession Number:
0001127602-21-009288
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-03 19:23:34
Reporting Period:
2021-03-01
Accepted Time:
2021-03-03 19:23:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
816956 Conmed Corp CNMD Electromedical & Electrotherapeutic Apparatus (3845) 160977505
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1238334 Daniel Jonas C/O Conmed Corp
11311 Concept Boulevard
Largo FL 33773
Evp Legal Affairs,Gen. Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-01 3,221 $39.87 16,929 No 4 M Direct
Common Stock Disposition 2021-03-01 3,221 $123.26 13,708 No 4 S Direct
Common Stock Acquisiton 2021-03-01 624 $41.93 14,332 No 4 M Direct
Common Stock Disposition 2021-03-01 624 $123.28 13,708 No 4 S Direct
Common Stock Acquisiton 2021-03-01 3,500 $41.93 17,208 No 4 M Direct
Common Stock Disposition 2021-03-01 2,345 $123.20 14,863 No 4 F Direct
Common Stock Acquisiton 2021-03-02 2,199 $39.87 17,062 No 4 M Direct
Common Stock Disposition 2021-03-02 2,199 $121.84 14,863 No 4 S Direct
Common Stock Acquisiton 2021-03-02 1,000 $41.93 15,863 No 4 M Direct
Common Stock Disposition 2021-03-02 1,000 $121.92 14,863 No 4 S Direct
Common Stock Disposition 2021-03-02 800 $0.00 14,063 No 5 G Direct
Common Stock Disposition 2021-03-02 150 $0.00 13,913 No 5 G Direct
Common Stock Disposition 2021-03-02 150 $0.00 13,763 No 5 G Direct
Common Stock Acquisiton 2021-03-02 150 $0.00 450 No 5 G Indirect daughter
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 5 G Direct
No 5 G Direct
No 5 G Direct
No 5 G Indirect daughter
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options To Purchase Common Stock Disposition 2021-03-01 3,221 $0.00 3,221 $39.87
Common Stock Options To Purchase Common Stock Disposition 2021-03-01 624 $0.00 624 $41.93
Common Stock Options To Purchase Common Stock Disposition 2021-03-01 3,500 $0.00 3,500 $41.93
Common Stock Options To Purchase Common Stock Acquisiton 2021-03-01 21,250 $0.00 21,250 $122.55
Common Stock Options To Purchase Common Stock Disposition 2021-03-02 2,199 $0.00 2,199 $39.87
Common Stock Options To Purchase Common Stock Disposition 2021-03-02 1,000 $0.00 1,000 $41.93
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,199 2026-03-01 No 4 M Direct
24,376 2027-03-01 No 4 M Direct
20,876 2027-03-01 No 4 M Direct
21,250 2031-03-01 No 4 A Direct
0 2026-03-01 No 4 M Direct
19,876 2027-03-01 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.25 to $123.49. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.25 to $123.405. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.80 to $122.22. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.80 to $122.33. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  5. The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
  6. The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period